Nisa Investment Advisors, LLC Johnson & Johnson Transaction History

Nisa Investment Advisors, LLC

$15.7 Billion
Q2 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 671,123 shares of JNJ stock, worth $108 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

671,123

Previous 674,828 0.55%

Holding current value

$108 Million

Previous $107 Million 8.11%

% of portfolio

0.63%

Previous 0.7%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$144.38 - $157.78 $534,927 - $584,574	-3,705 Reduced 0.55%	671,123 $98.1 Million
Q1 2024 May 01, 2024	SELL	$155.22 - $162.74 $1.66 Million - $1.74 Million	-10,671 Reduced 1.56%	674,828 $107 Million
Q4 2023 Jan 25, 2024	SELL	$145.6 - $158.88 $5.06 Million - $5.52 Million	-34,729 Reduced 4.82%	685,499 $107 Million
Q3 2023 Nov 02, 2023	SELL	$155.75 - $174.48 $4.02 Million - $4.5 Million	-25,806 Reduced 3.46%	720,228 $112 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $433,414 - $466,436	-2,808 Reduced 0.37%	746,034 $123 Million
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $1.03 Million - $1.23 Million	6,836 Added 0.92%	748,842 $116 Million
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $2.54 Million - $2.85 Million	-15,858 Reduced 2.09%	742,006 $131 Million
Q3 2022 Nov 07, 2022	BUY	$161.33 - $179.52 $546,263 - $607,854	3,386 Added 0.45%	757,864 $124 Million
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $2.35 Million - $2.6 Million	-13,994 Reduced 1.82%	754,478 $134 Million
Q1 2022 Apr 29, 2022	SELL	$158.14 - $179.59 $22.9 Million - $26 Million	-144,950 Reduced 15.87%	768,472 $136 Million
Q4 2021 Feb 03, 2022	BUY	$155.93 - $173.01 $21.2 Million - $23.5 Million	136,043 Added 17.5%	913,422 $157 Million
Q3 2021 Oct 18, 2021	SELL	$161.5 - $179.47 $1.31 Million - $1.46 Million	-8,130 Reduced 1.03%	777,379 $126 Million
Q2 2021 Aug 06, 2021	SELL	$159.48 - $171.07 $21.1 Million - $22.6 Million	-132,314 Reduced 14.42%	785,509 $129 Million
Q1 2021 Apr 26, 2021	SELL	$153.07 - $170.48 $6.38 Million - $7.11 Million	-41,696 Reduced 4.35%	917,823 $151 Million
Q4 2020 Jan 25, 2021	BUY	$137.11 - $157.38 $1.41 Million - $1.62 Million	10,298 Added 1.08%	959,519 $151 Million
Q3 2020 Oct 20, 2020	SELL	$140.38 - $153.83 $3.37 Million - $3.7 Million	-24,026 Reduced 2.47%	949,221 $141 Million
Q2 2020 Jul 27, 2020	BUY	$128.81 - $155.51 $1.32 Million - $1.6 Million	10,277 Added 1.07%	973,247 $137 Million
Q1 2020 Apr 17, 2020	BUY	$111.14 - $153.99 $2.45 Million - $3.4 Million	22,055 Added 2.34%	962,970 $126 Million
Q4 2019 Jan 17, 2020	SELL	$127.5 - $146.44 $4.6 Million - $5.28 Million	-36,047 Reduced 3.69%	940,915 $137 Million
Q3 2019 Oct 17, 2019	SELL	$126.95 - $142.14 $2.72 Million - $3.05 Million	-21,447 Reduced 2.15%	976,962 $126 Million
Q2 2019 Jul 12, 2019	SELL	$131.15 - $144.24 $4.28 Million - $4.71 Million	-32,631 Reduced 3.16%	998,409 $139 Million
Q1 2019 Apr 17, 2019	SELL	$125.72 - $139.79 $2.59 Million - $2.88 Million	-20,591 Reduced 1.96%	1,031,040 $144 Million
Q4 2018 Jan 17, 2019	BUY	$122.84 - $147.84 $5.37 Million - $6.46 Million	43,691 Added 4.33%	1,051,631 $136 Million
Q3 2018 Oct 16, 2018	BUY	$121.58 - $142.88 $2.03 Million - $2.38 Million	16,684 Added 1.68%	1,007,940 $139 Million
Q2 2018 Jul 19, 2018	SELL	$119.4 - $131.76 $4.26 Million - $4.7 Million	-35,677 Reduced 3.47%	991,256 $120 Million
Q1 2018 Apr 10, 2018	SELL	$125.1 - $148.14 $439,351 - $520,267	-3,512 Reduced 0.34%	1,026,933 $132 Million
Q4 2017 Jan 12, 2018	SELL	$131.22 - $143.62 $2.13 Million - $2.33 Million	-16,235 Reduced 1.55%	1,030,445 $144 Million
Q3 2017 Oct 13, 2017	BUY	$129.47 - $135.38 $136 Million - $142 Million	1,046,680	1,046,680 $136 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $422B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Johnson & Johnson Transaction History